Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Haller

Showing results (461-470 of 795) with videos related to

Pageof 80
Sort By:
Diabetes Care|September 14, 2023
Hydroxychloroquine in Stage 1 Type 1 DiabetesIngrid Libman, Polly J Bingley, Dorothy Becker, et al.
Diabetes Care|July 18, 2018
Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA<sub>1c</sub> in New-Onset Type 1 DiabetesMichael J Haller, Desmond A Schatz, Jay S Skyler, et al.
JCI Insight|July 27, 2023
Human immune phenotyping reveals accelerated aging in type 1 diabetesMelanie R Shapiro, Xiaoru Dong, Daniel J Perry, et al.
Diabetes, Obesity & Metabolism|September 30, 2024
Developing an automated algorithm for identification of children and adolescents with diabetes using electronic health records from the OneFlorida+ clinical research networkPiaopiao Li, Eliot Spector, Khalid Alkhuzam, et al.
Nature Reviews. Endocrinology|November 4, 2024
Looking back at the TEDDY study: lessons and future directionsÅke Lernmark, Daniel Agardh, Beena Akolkar, et al.
BMJ Open|December 8, 2021
Study protocol: Minimum effective low dose: anti-human thymocyte globulin (MELD-ATG): phase II, dose ranging, efficacy study of antithymocyte globulin (ATG) within 6 weeks of diagnosis of type 1 diabetesCharlotte S Wilhelm-Benartzi, Sarah E Miller, Sylvaine Bruggraber, et al.
Oral Oncology|September 17, 2023
Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated diseaseKathleen R Bartemes, Benjamin R Gochanour, David M Routman, et al.
Diabetes Care|April 24, 2025
Unfolding the Mystery of Autoimmunity: The Environmental Determinants of Diabetes in the Young (TEDDY) StudyMarian Rewers, Daniel Agardh, Suzanne Bennett Johnson, et al.
JMIR Diabetes|August 3, 2023
The Promising Success of Project Extension for Community Healthcare Outcomes (ECHO) Diabetes: Case SeriesLauren Figg, Ananta Addala, Ishaan Jain, et al.
Diabetes|April 11, 2019
Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA<sub>1c</sub>, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial DataMichael J Haller, S Alice Long, J Lori Blanchfield, et al.
Pageof 80

Showing results (461-470 of 795) with videos related to

Sort By:
Pageof 80
Diabetes Care|September 14, 2023
Hydroxychloroquine in Stage 1 Type 1 DiabetesIngrid Libman, Polly J Bingley, Dorothy Becker, et al.
Diabetes Care|July 18, 2018
Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA<sub>1c</sub> in New-Onset Type 1 DiabetesMichael J Haller, Desmond A Schatz, Jay S Skyler, et al.
JCI Insight|July 27, 2023
Human immune phenotyping reveals accelerated aging in type 1 diabetesMelanie R Shapiro, Xiaoru Dong, Daniel J Perry, et al.
Diabetes, Obesity & Metabolism|September 30, 2024
Developing an automated algorithm for identification of children and adolescents with diabetes using electronic health records from the OneFlorida+ clinical research networkPiaopiao Li, Eliot Spector, Khalid Alkhuzam, et al.
Nature Reviews. Endocrinology|November 4, 2024
Looking back at the TEDDY study: lessons and future directionsÅke Lernmark, Daniel Agardh, Beena Akolkar, et al.
BMJ Open|December 8, 2021
Study protocol: Minimum effective low dose: anti-human thymocyte globulin (MELD-ATG): phase II, dose ranging, efficacy study of antithymocyte globulin (ATG) within 6 weeks of diagnosis of type 1 diabetesCharlotte S Wilhelm-Benartzi, Sarah E Miller, Sylvaine Bruggraber, et al.
Oral Oncology|September 17, 2023
Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated diseaseKathleen R Bartemes, Benjamin R Gochanour, David M Routman, et al.
Diabetes Care|April 24, 2025
Unfolding the Mystery of Autoimmunity: The Environmental Determinants of Diabetes in the Young (TEDDY) StudyMarian Rewers, Daniel Agardh, Suzanne Bennett Johnson, et al.
JMIR Diabetes|August 3, 2023
The Promising Success of Project Extension for Community Healthcare Outcomes (ECHO) Diabetes: Case SeriesLauren Figg, Ananta Addala, Ishaan Jain, et al.
Diabetes|April 11, 2019
Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA<sub>1c</sub>, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial DataMichael J Haller, S Alice Long, J Lori Blanchfield, et al.
Pageof 80